What happened
Humedix reported separate results for FY2025: revenue of US$118M (+5.1% year on year), operating profit of US$29.4M (−1.9% year on year) and net income of US$34.7M (+27.2% year on year).
Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.
| Revenue | US$118M |
|---|---|
| Revenue vs a year earlier | +5.1% |
| Operating profit | US$29.4M |
| Net income | US$34.7M |
| Period | FY2025 (separate) |
| Filed | 2026-02-13, Change of less than 30% in revenue or profit/loss structure (15% for large companies) (voluntary) |
| Source | DART rcept 20260213901540 → open original filing |
Source: DART. Information only, not investment advice.